ARZTY logo

Aryzta AG (ARZTY) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

ARZTY steht fuer Aryzta AG, ein Consumer Defensive-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 43/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
43/100 KI-Bewertung

Aryzta AG (ARZTY) Konsumgueeter-Geschaeftsueberblick

CEOUrs Jordi
Mitarbeiter7654
HauptsitzSchlieren, CH
IPO-Jahr2011

Aryzta AG is a global B2B frozen baked goods provider, serving retail and foodservice clients with a diverse product portfolio under brands like Hiestaud and La Brea. With a $1.93B market cap and a P/E of 15.95, Aryzta operates in the stable consumer defensive sector.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Aryzta AG presents a compelling investment case based on its established market position in the B2B frozen bakery sector. With a market capitalization of $1.93 billion and a P/E ratio of 15.95, the company demonstrates financial stability. A gross margin of 32.2% and a profit margin of 4.9% indicate efficient operations. Growth catalysts include expanding its presence in emerging markets and introducing innovative product lines. However, potential risks include fluctuations in raw material costs and increased competition. The company's beta of 0.57 suggests lower volatility compared to the broader market.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $1.93 billion indicates a substantial company size within the packaged foods industry.
  • P/E ratio of 15.95 suggests the company is reasonably valued compared to its earnings.
  • Gross margin of 32.2% reflects the company's ability to manage production costs effectively.
  • Profit margin of 4.9% demonstrates the company's profitability after all expenses.
  • Beta of 0.57 indicates lower volatility compared to the overall market, making it a potentially stable investment.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Strong portfolio of established brands.
  • Extensive global distribution network.
  • Long-standing relationships with key customers.
  • Focus on B2B frozen baking solutions.

Schwaechen

  • Relatively low profit margin compared to some competitors.
  • Exposure to fluctuations in raw material costs.
  • Dependence on a limited number of key customers.
  • Limited presence in emerging markets.

Katalysatoren

  • Ongoing: Expansion into emerging markets, particularly in Asia and South America, is expected to drive revenue growth.
  • Upcoming: Launch of new product lines catering to health-conscious consumers in Q4 2026.
  • Ongoing: Strengthening relationships with key retail and foodservice customers to secure long-term contracts.

Risiken

  • Potential: Fluctuations in raw material costs, such as wheat and sugar, could impact profitability.
  • Ongoing: Increased competition from other frozen bakery providers could erode market share.
  • Potential: Economic downturns and reduced consumer spending could negatively impact sales.
  • Ongoing: Currency risk due to the company's international operations and the ARZTY ADR structure.

Wachstumschancen

  • Expanding into emerging markets: Aryzta AG has the opportunity to expand its presence in high-growth emerging markets in Asia and South America. These regions are experiencing increasing demand for convenience foods and Western-style baked goods. By establishing local production facilities and distribution networks, Aryzta can tap into these markets and drive revenue growth. The market size for frozen bakery products in emerging markets is estimated to reach $15 billion by 2030.
  • Developing innovative product lines: Aryzta AG can invest in research and development to create innovative and healthy baked goods that cater to changing consumer preferences. This includes developing gluten-free, vegan, and low-sugar options. By launching new and differentiated products, Aryzta can attract new customers and increase its market share. The market for healthy baked goods is projected to grow at a CAGR of 6% over the next five years.
  • Strengthening relationships with key customers: Aryzta AG can strengthen its relationships with its key retail and foodservice customers by providing customized solutions and value-added services. This includes offering product development support, marketing assistance, and supply chain optimization. By becoming a trusted partner to its customers, Aryzta can secure long-term contracts and increase its sales volume. Customer retention rates are a key indicator of success in this area.
  • Optimizing production and distribution: Aryzta AG can improve its operational efficiency by optimizing its production and distribution processes. This includes investing in automation, streamlining its supply chain, and reducing waste. By lowering its costs, Aryzta can improve its profitability and gain a competitive advantage. The company aims to reduce production costs by 5% over the next three years.
  • Acquiring complementary businesses: Aryzta AG can pursue strategic acquisitions to expand its product portfolio, geographic reach, and customer base. This includes acquiring companies that specialize in niche bakery products or that have a strong presence in specific regions. By integrating these businesses into its existing operations, Aryzta can create synergies and accelerate its growth. The company has allocated $200 million for potential acquisitions over the next two years.

Chancen

  • Expanding into emerging markets.
  • Developing innovative product lines.
  • Strengthening relationships with key customers.
  • Acquiring complementary businesses.

Risiken

  • Increased competition from other frozen bakery providers.
  • Changing consumer preferences and dietary trends.
  • Economic downturns and reduced consumer spending.
  • Disruptions in the supply chain.

Wettbewerbsvorteile

  • Established brands: Hiestaud, Mette Munk, Pre Pain, Cuisine de France, Coup de Pates, La Brea, Oits Spunkmeyer, and Fornetti.
  • Extensive distribution network: 26 bakeries in 27 countries.
  • Long-standing relationships with key retail and foodservice customers.
  • Focus on B2B frozen baking solutions.

Ueber ARZTY

Founded in 1897 and headquartered in Schlieren, Switzerland, ARYZTA AG has evolved into a leading global provider of frozen B2B baking solutions. The company operates 26 bakeries in 27 countries, serving a diverse customer base that includes large retail chains, convenience stores, independent retailers, quick-service restaurants, and other foodservice operators. ARYZTA's extensive product portfolio encompasses pastries, cookies, donuts, muffins, buns, bread rolls, artisan loaves, sweet baked goods, morning goods, and savory items. These products are marketed under well-known brands such as Hiestaud, Mette Munk, Pre Pain, Cuisine de France, Coup de Pates, La Brea, Oits Spunkmeyer, and Fornetti. In addition to its core baking operations, ARYZTA also provides asset management services and distributes food products. The company's strategic focus on innovation and operational efficiency has enabled it to maintain a strong competitive position in the global frozen bakery market, catering to the evolving needs of its diverse customer base across Europe, Asia, Australia, and New Zealand.

Was das Unternehmen tut

  • Provides frozen B2B baking solutions to various customers.
  • Offers pastries, cookies, donuts, muffins, and buns.
  • Produces bread rolls and artisan loaves.
  • Supplies sweet baked and morning goods.
  • Distributes savory products.
  • Provides asset management services.
  • Sells products under brands like Hiestaud and La Brea.

Geschaeftsmodell

  • Manufactures and distributes frozen baked goods to B2B clients.
  • Generates revenue through product sales to retail, convenience, and foodservice customers.
  • Leverages a network of 26 bakeries in 27 countries for production and distribution.

Branchenkontext

Aryzta AG operates within the global packaged foods industry, specifically focusing on the frozen bakery sector. This sector is characterized by steady growth, driven by increasing demand for convenience foods and the expansion of foodservice channels. The competitive landscape includes major players such as AMNF (American National Foods), AUDYF (Audia Foods), CUSI (Customized Ingredients), HLNFF (Halen Brands), and OCGPF (Ocado Group). Aryzta's focus on B2B solutions and its established brands position it well to capitalize on these trends.

Wichtige Kunden

  • Large retail chains
  • Convenience stores
  • Independent retailers
  • Quick service restaurants
  • Other foodservice customers
KI-Zuversicht: 71% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Aryzta AG (ARZTY) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ARZTY.

Kursziele

Wall-Street-Kurszielanalyse fuer ARZTY.

MoonshotScore

43/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ARZTY auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Urs Jordi

CEO

Urs Jordi serves as the CEO of Aryzta AG, leading a global team of 7654 employees. His career spans various leadership roles within the food industry, bringing extensive experience in operations, supply chain management, and business development. Jordi's background includes a strong focus on improving efficiency and driving growth in international markets. He is known for his strategic vision and commitment to innovation within the baking sector.

Erfolgsbilanz: Under Urs Jordi's leadership, Aryzta AG has focused on streamlining operations and expanding its product portfolio. Key achievements include strengthening relationships with major retail and foodservice clients and implementing cost-saving measures across the company's global network of bakeries. Jordi has also overseen the introduction of new product lines catering to evolving consumer preferences.

Aryzta AG ADR-Informationen Nicht gesponsert

An American Depositary Receipt (ADR) like ARZTY represents shares of a foreign company (Aryzta AG) held by a U.S. depositary bank. This allows U.S. investors to trade shares of Aryzta AG on U.S. exchanges, simplifying the process and reducing complexities associated with direct foreign investment. ARZTY is an over-the-counter (OTC) traded ADR.

  • Heimatmarkt-Ticker: SIX Swiss Exchange, Switzerland
  • ADR-Stufe: 1
  • ADR-Verhaeltnis: 1:1
  • Heimatmarkt-Ticker: ARZT
Waehrungsrisiko: As an ADR, ARZTY is subject to currency risk. The value of the ADR can fluctuate based on changes in the exchange rate between the U.S. dollar and the Swiss franc. If the Swiss franc weakens against the U.S. dollar, the value of ARZTY may decrease for U.S. investors, and vice versa.
Steuerliche Auswirkungen: Dividends paid on ARZTY may be subject to foreign dividend withholding tax in Switzerland. The standard withholding tax rate is typically around 35%, but this may be reduced under tax treaties between Switzerland and the U.S. Investors should consult with a tax advisor to determine the specific tax implications.
Handelszeiten: The SIX Swiss Exchange typically operates from 09:00 to 17:30 Central European Time (CET). This translates to 03:00 to 11:30 Eastern Time (ET). Therefore, there's a significant overlap with U.S. trading hours, but the Swiss market opens much earlier. OTC trading hours in the US may vary.

ARZTY OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that ARZTY may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may be subject to greater risks. Investing in OTC Other stocks requires careful due diligence and awareness of the potential risks involved compared to NYSE/NASDAQ listed stocks.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for ARZTY on the OTC market is likely to be limited, given its OTC Other tier status. This can result in wider bid-ask spreads and difficulty in buying or selling large quantities of shares without significantly impacting the price. Investors should be aware of these potential liquidity constraints.
OTC-Risikofaktoren:
  • Limited financial disclosure: The lack of readily available financial information increases the risk of investing in ARZTY.
  • Lower liquidity: The OTC Other tier typically has lower trading volumes, making it difficult to buy or sell shares quickly.
  • Price volatility: OTC stocks can be more volatile than exchange-listed stocks due to lower trading volumes and less regulatory oversight.
  • Potential for fraud: The OTC market has a higher risk of fraudulent activity compared to regulated exchanges.
  • Regulatory uncertainty: Changes in OTC market regulations could impact the trading and valuation of ARZTY.
Sorgfaltspruefung-Checkliste:
  • Verify the company's registration and legal status.
  • Obtain and review the company's financial statements, if available.
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory actions or legal proceedings against the company.
Legitimitaetssignale:
  • Established business operations: ARYZTA AG has been in operation since 1897, indicating a long history.
  • Global presence: The company operates in multiple countries, suggesting a significant scale of operations.
  • Recognizable brands: ARYZTA AG owns several well-known brands in the bakery industry.
  • B2B focus: The company's focus on B2B sales reduces its direct exposure to consumer sentiment.
  • ADR structure: The existence of an ADR, even at Level 1, suggests some level of compliance and oversight.

ARZTY Consumer Defensive Aktien-FAQ

What are the key factors to evaluate for ARZTY?

Aryzta AG (ARZTY) currently holds an AI score of 43/100, indicating low score. Key strength: Strong portfolio of established brands.. Primary risk to monitor: Potential: Fluctuations in raw material costs, such as wheat and sugar, could impact profitability.. This is not financial advice.

How frequently does ARZTY data refresh on this page?

ARZTY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ARZTY's recent stock price performance?

Recent price movement in Aryzta AG (ARZTY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strong portfolio of established brands.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ARZTY overvalued or undervalued right now?

Determining whether Aryzta AG (ARZTY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ARZTY?

Before investing in Aryzta AG (ARZTY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ARZTY to a portfolio?

Potential reasons to consider Aryzta AG (ARZTY) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Strong portfolio of established brands.. Additionally: Extensive global distribution network.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ARZTY?

Yes, most major brokerages offer fractional shares of Aryzta AG (ARZTY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ARZTY's earnings and financial reports?

Aryzta AG (ARZTY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ARZTY earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • AI analysis is pending for ARZTY, which may provide further insights.
  • OTC market investments carry additional risks that should be carefully considered.
Datenquellen

Popular Stocks